WTAP increased hepatocellular carcinoma cell proliferation and tumor growth in vitro and in vivo via the m6A-HuR-dependent epigenetic silencing of ETS1 in vitro and in vivo (32). The gene discussed is ELAVL1; the disease is hepatocellular carcinoma.